UK markets close in 6 hours 22 minutes
  • FTSE 100

    6,645.42
    -8.59 (-0.13%)
     
  • FTSE 250

    20,489.06
    +40.70 (+0.20%)
     
  • AIM

    1,198.31
    -0.10 (-0.01%)
     
  • GBP/EUR

    1.1326
    +0.0035 (+0.31%)
     
  • GBP/USD

    1.3733
    +0.0001 (+0.01%)
     
  • BTC-GBP

    22,815.14
    -540.91 (-2.32%)
     
  • CMC Crypto 200

    629.01
    -10.90 (-1.70%)
     
  • S&P 500

    3,849.62
    -5.74 (-0.15%)
     
  • DOW

    30,937.04
    -22.96 (-0.07%)
     
  • CRUDE OIL

    52.89
    +0.28 (+0.53%)
     
  • GOLD FUTURES

    1,844.50
    -6.40 (-0.35%)
     
  • NIKKEI 225

    28,635.21
    +89.03 (+0.31%)
     
  • HANG SENG

    29,297.53
    -93.73 (-0.32%)
     
  • DAX

    13,819.69
    -51.30 (-0.37%)
     
  • CAC 40

    5,524.87
    +1.35 (+0.02%)
     

Nasal delivery devices Market Forecast to 2027: Global COVID-19 Impact and Analysis by Drug Type, Delivery Technologies, End User

Research and Markets
·4-min read

Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "Nasal delivery devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Type; Delivery Technologies; End User, and Geography" report has been added to ResearchAndMarkets.com's offering.

The market is expected to reach US$ 95,676.62 million by2027 from US$ 58,502.18 million in 2019. The market is estimated to grow with a CAGR of 6.4% from 2020 to 2027.

Based on delivery technologies, the market is segmented in to spray, nebulizers, inhalers, and others. In 2019, the inhalers segment held the largest share of the market and is expected to grow at the fastest CAGR during the forecast period. An inhaler (also known as a pump, puffer, or allergy spray) is a nasal delivery device used for delivering medicines into the lungs via person's breathing mechanism.

This device helps deliver medical treatment to the targeted region of the body, thereby reducing the side effects of oral medications. There are a wide variety of inhalers that are used to treat numerous medical conditions, such as asthma and chronic obstructive pulmonary disease (COPD).

Some of the common types of inhalers include meter-dosed inhalers, dry powder inhalers, soft mist inhalers, and others. There are certain types of inhalers containing drugs in it for the treatment of asthma and COPD such as , reliever inhalers: contain bronchodilator medicines, preventer inhalers: contain a steroid medicine.

GlaxoSmithKline plc.; AstraZeneca; Pfizer Inc.; BD; Sanofi; Merck & Co.Inc.; Cadila Pharmaceuticals Ltd.; Novartis AG; Dr. Reddy's Laboratories; and Neurelis, Inc. are among the leading companies operating in the nasal delivery devices market.

Key Topics Covered:

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation

2. Nasal Delivery Devices Market - Key Takeaways

3. Research Methodology

4. Global Nasal Delivery Devices Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion

5. Nasal Delivery Devices Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Prevalence of Respiratory and CNS Diseases
5.1.2 Increasing Preference and Awareness Among Patients
5.2 Market Restraints
5.2.1 Challenges Associated with Nasal Administration of Drugs
5.3 Market Opportunities
5.3.1 Rising Adoption of Self-Administration Practices
5.4 Future Trends
5.4.1 Consolidation of Nasal Delivery Device Industry
5.5 Impact Analysis

6. Nasal Delivery Devices Market - Global Analysis
6.1 Global Nasal Delivery Devices Market Revenue Forecast And Analysis
6.2 Global Nasal Delivery Devices Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players

7. Nasal Delivery Devices Market Analysis - By Drug Type
7.1 Overview
7.2 Nasal Delivery Devices Market Revenue Share, by Drug Type (2019 and 2027)
7.3 Anesthetics
7.3.1 Overview
7.3.2 Anesthetics: Nasal Delivery Devices - Revenue and Forecast to 2027 (US$ Million)
7.4 Antibiotics
7.5 Pain Relief Drugs
7.6 Calcium Supplements
7.7 Vasoconstrictors
7.8 Antihistamines

8. Nasal Delivery Devices Market Analysis - By Delivery Technologies
8.1 Overview
8.2 Nasal Delivery Devices Market Revenue Share, by Delivery Technologies (2019 and 2027)
8.3 Spray
8.3.1 Overview
8.3.2 Spray: Nasal Delivery Devices - Revenue and Forecast to 2027 (US$ Million)
8.4 Nebulizers
8.5 Inhalers

9. Nasal Delivery Devices Market Analysis - By End -User
9.1 Overview
9.2 Nasal Delivery Devices Market Revenue Share, by End -User (2019 and 2027)
9.3 Home Care Setting
9.3.1 Overview
9.3.2 Home Care Setting: Nasal Delivery Devices - Revenue and Forecast to 2027 (US$ Million)
9.4 Hospitals
9.5 Clinics

10. Nasal Delivery Devices Market - Geographic Analysis

11. Impact of COVID-19 Pandemic on Global Nasal Delivery Devices Market

12. Nasal Delivery Devices Market- Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.4 Inorganic Developments

13. Company Profiles
13.1 Key Facts
13.2 Business Description
13.3 Products and Services
13.4 Financial Overview
13.5 SWOT Analysis
13.6 Key Developments

  • GlaxoSmithKline plc.

  • AstraZeneca

  • Pfizer Inc.

  • BD

  • Sanofi

  • Merck & Co., Inc.

  • Cadila Pharmaceuticals Ltd.

  • Novartis AG

  • Dr. Reddy's Laboratories

  • Neurelis, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/v0xqp0

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900